Marketwatch
Intel’s stock soars as the company’s ‘blue-chip roster’ of customers looks to be growing
Investors are cheering the idea that Intel could serve as a backup chip manufacturer for Nvidia and Google....
Micron’s stock bounces back in a big way: ‘The memory trade is alive and well’
Long-term supply agreements are altering memory companies’ long-term earnings potential for the better, an analyst said....
This Big Tech investor’s warning for traders: Watch out for the SpaceX IPO
Brad Gerstner, CEO of tech investor Altimeter Capital, said retail investors are facing some potentially tricky times ahead with big tech IPOs....
Why Elon Musk says ASML is the greatest company in Europe
For Elon Musk’s ambitious Terafab project in Texas to be successful, Musk is going to need lots of ASML’s industry-leading lithography machines....
I’m 65, widowed and collecting Social Security survivor benefits. Should I claim my own benefits now?
“I am concerned that benefits could be reduced or even discontinued if Social Security runs out of money in the coming years.”...
Filed an extension for your income taxes? The IRS is still charging you.
An extension delays paperwork, but not your payment. Settle your estimated bill now to stop daily IRS penalties....
Gold just had its worst selloff since March. A floor may be $4,000, says one veteran strategist
Gold’s slump has followed Friday’s better-than-expected May U.S. employment report....
Why tech’s record pullback is just a ‘healthy reset’ for the bull market, according to Morgan Stanley’s top stock-market strategist
Improving earnings and economic backdrop support stocks, says Morgan Stanley’s Wilson....
My golf buddy worked as a financial adviser. Here’s how I really knew his friendship was fake.
“He always mentioned how popular I was.”...
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts....
What nine different indicators say about market exuberance, according to Goldman Sachs
Goldman Sachs’ research illustrates that while the stock market is closer to a dangerous bubble than it was a few months ago, an overall assessment of risk indicators is not that alarming....
‘I have no experience with investing’: I inherited $2,000. I’m 42 with two children. What should I do with this money?
“I would like the money to grow.”...
Alanis Morissette quickly sells her Bay Area estate in lucrative $9.6 million sale
Acclaimed singer Alanis Morissette has proven that she can conquer not only the music charts, but also the real estate market....
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues....
Nvidia strikes a new memory-chip deal — but SK Hynix and Samsung shares are under heavy pressure
South Korea’s once-hot Kospi index is headed for another day of sharp declines as the AI trade loses steam....
The Wegovy pill is still dominating the GLP-1 pill market
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill....
U.S. stock futures slide, oil prices surge as new attacks threaten the cease-fire with Iran
U.S. stock-index futures fell on Sunday, after a massive tech selloff on Friday interrupted Wall Street’s two-month rally, and after new developments threatened the fragile cease-fire in the Iran war....
S&P 500 companies can’t stop talking about higher oil prices. But few say they’ll actually hurt profits.
Only seven companies cited oil prices as a reason for cutting or not updating their profit outlooks for the year....
These are the market’s new hot stocks as investors flee from tech
Investors are suddenly dumping technology stocks and rotating into other areas — including health insurers, banks and retailers....
Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.
There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s....
South Korea is the ultimate backdoor tech play — but stock investors now face a looming threat
Samsung and SK Hynix are key to soaring South Korean stock market, but a rate hike could trigger a 15% market correction....
Don’t rule out a ‘June swoon’ — the S&P 500 is pushing its limits
Even upbeat Oracle earnings next week might not be enough to rally the market....
The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio
Low-volatility stocks give investors a smoother ride — and they are beating the market on a risk-adjusted basis....
The blowout jobs report is bad news for stocks — but it shouldn’t force the Fed’s hand on interest rates
Rate hikes now will choke off the critical investments needed to lower prices....
Can SpaceX live up to Wall Street’s multitrillion-dollar hype?
As SpaceX prepares for the biggest public debut in history, some analysts warn that the company’s “moonshot” projections could fall short....
America’s crude inventories are getting perilously low. But that’s not the full story.
U.S. commercial oil inventories may be too low for comfort as the war with Iran enters its fourth month far from a clear resolution — and a lot is riding on how much longer the conflict drags on....
Apple’s WWDC will be a make-or-break moment for the company’s fledgling AI strategy
At Monday’s keynote, Apple will get a second chance to show users it can make Siri smarter and more contextually aware....
‘He’s very short-tempered’: My husband won’t sell his home so we can combine our finances and live in comfort. Am I unreasonable?
“Our homes are 20 miles apart, and he still drives back and forth almost daily.”...
S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record. Here’s what investors need to know about Friday’s selloff.
A remarkable two-month sprint higher for major stock-market indexes encountered its first major hiccup on Friday as the Nasdaq Composite plummeted more than 1,121 points — the biggest one day point dr...
The hiring recession is over — but landing a new role is much harder than it looks
The May jobs report blew past forecasts. Why is it taking six months to find a new job?...
For the first time ever, an S&P 500 ETF has over $1 trillion in assets. Here’s why that should worry you.
Welcome to the age of trillions....
This hot new financial product has Wall Street spooked. What you should know before trying it out.
Perpetual futures have finally arrived in the U.S. Not everyone is thrilled....
Nearly half of workers 55 and older don’t plan on using AI in their jobs. How to make it work for you.
Workers can learn more about applying AI to their jobs even on social-media platforms, such as YouTube and TikTok, one career coach said....
An S&P 500 shakeup is hours away. These stocks could soon earn spots in the index.
Marvell, Reddit and a mortgage “dark horse” could make the cut during the next quarterly rebalancing of the benchmark index....
Will you be audited by Trump’s IRS? New data says there’s one group that can breathe a lot easier.
A new report out Friday reflects IRS audit activity and other operations at the start of the second Trump presidency....
This credit-card pointsmaxxer booked a $16,000 first-class Emirates flight for $400 — and you can, too
It’s trickier to find good deals with airline miles, but it’s still possible to get “insane value.”...
A ‘rudderless’ Lululemon needs to ditch logos and get back to basics, analysts say
“Make the color palette normal again,” one analyst said, as Lululemon’s stock sinks toward its lowest close since May 2018....
If the semiconductor rally loses steam, it’s retail investors who could get hurt the most
May was the strongest month of the year for buying by retail investors, as individuals piled into semiconductor stocks....
Here’s what wild single-stock price swings may signal for your index fund
Also in Weekend Reads: The latest on SpaceX and other IPOs, a raw deal for Alphabet’s non-Berkshire shareholders and advice from the Moneyist....
‘DOGE’ wanted to declare 2.7 million people ‘dead’ at Social Security: whistleblower
This is the third whistleblower to come forward about alleged illegal activity by Trump’s Department of Government Efficiency....
J.P. Morgan ends bearish Tesla call that was predicting a 65% stock drop
A new analyst has taken over the bank’s Tesla coverage, and he has a less gloomy view of Elon Musk’s EV company....
Elon Musk needs the cultish support of everyday investors to pull off the massive SpaceX IPO
“They’re going to have to own it”: Elon Musk wants retail investors to buy some $23 billion of SpaceX shares next week....
A new blood test can help detect colon cancer, but it’s not as good as the test you hate to take
About 50 million Americans aren’t getting screened for colon cancer at a time when colon-cancer rates are rising....
Here’s the downside to record-setting stock markets across the globe that are generating a wealth boom
While some Americans are enjoying the fruits of the stock market bonanza, their consumption is stirring inflation and lower-income consumers are missing out altogether, says Bank of America....
The IPO of this power generator for data centers quietly outshines Quantinuum
Innio’s stock soared in its debut, to outshine the shares of the more high-profile quantum-computing company, and Trump administration investment, Quantinuum....
Walmart’s stock was once a market darling. Now its tech-fueled valuation faces a reality check.
Walmart shares have lagged peers and the S&P 500 this year, with some analysts noting that business is still dominated by low-margin grocery sales....
Bulls declare victory on AI, but two classic signs of a market top are looming
The trend of ‘capex recycling’ is considered a problem by a TS Lombard analyst...
We thought we found the perfect luxury retirement community, but it’s millions of dollars in debt. Are we trapped?
“If we were to leave, we would lose a portion of our buy-in — about $80,000.”...
What SpaceX is really worth, according to the professor called the dean of valuation
Aswath Damodaran, the New York University finance professor with the nickname the “dean of valuation,” had estimated, before getting a look at the prospectus, that SpaceX was worth $1.2 trillion. What...
‘This would be a one-time event’: How can I take extra money from my 401(k) without triggering higher Medicare premiums?
“I generally withdraw money from my traditional 401(k) for projects, larger expenses and sometimes just to stay ahead on upcoming bills.”...





English (US)